JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M110083200 on November 8, 2001

J. Biol. Chem., Vol. 277, Issue 6, 4199-4205, February 8, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/6/4199    most recent
M110083200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Purkiss, A. G.
Right arrow Articles by Slingsby, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Purkiss, A. G.
Right arrow Articles by Slingsby, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The X-ray Crystal Structure of Human gamma S-crystallin C-terminal Domain*

Andrew G. PurkissDagger §, Orval A. BatemanDagger , Julia M. GoodfellowDagger , Nicolette H. Lubsen, and Christine SlingsbyDagger

From the Dagger  School of Crystallography, Birkbeck College, Malet Street, London WC1E 7HX, United Kingdom and the  Department of Biochemistry, University of Nijmegen, 6500 HB Nijmegen, The Netherlands

Received for publication, October 18, 2001, and in revised form, November 6, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

gamma S-crystallin is a major human lens protein found in the outer region of the eye lens, where the refractive index is low. Because crystallins are not renewed they acquire post-translational modifications that may perturb stability and solubility. In common with other members of the beta gamma -crystallin superfamily, gamma S-crystallin comprises two similar beta -sheet domains. The crystal structure of the C-terminal domain of human gamma S-crystallin has been solved at 2.4 Å resolution. The structure shows that in the in vitro expressed protein, the buried cysteines remain reduced. The backbone conformation of the "tyrosine corner" differs from that of other beta gamma -crystallins because of deviation from the consensus sequence. The two C-terminal domains in the asymmetric unit are organized about a slightly distorted 2-fold axis to form a dimer with similar geometry to full-length two-domain family members. Two glutamines found in lattice contacts may be important for short range interactions in the lens. An asparagine known to be deamidated in human cataract is located in a highly ordered structural region.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The lens crystallins are protein molecules that need to last a lifetime, because they are found in cells that have no protein synthetic or degradation machinery (1). The leading senile cataract hypothesis is that aged non-native crystallin molecules overwhelm the binding capacity of the small heat shock protein alpha -crystallin (also found in the lens), resulting in aggregation and formation of light scattering centers (2). Detailed molecular information from selected crystallin domains and proteins is needed to model their unfolding and characterize their likely ensemble biophysical properties, particularly the early unfolding intermediates that have been hypothesized to bind to alpha -crystallin (3). As a first step toward providing detailed molecular information on a major human lens crystallin involved in cataract, we have solved the x-ray crystal structure of the C-terminal domain from human gamma S-crystallin.

The crystallins are a well studied family of proteins for which there are several three-dimensional structures (4) as well as thermodynamic and kinetic data on folding/unfolding (5-7). The polypeptides of the ~13-member beta gamma -crystallin superfamily each comprise similar ~10-kDa N- and C-terminal domains that are themselves formed from two symmetrically organized Greek key motifs. In all cases, the N- and C-terminal domains pair about a similar pseudo-2-fold axis, with the domains in monomeric gamma -crystallins being covalently connected, whereas domain swapping can lead to dimerization in beta -crystallins (8).

There are seven genes coding for gamma -crystallins in vertebrate lenses (9), and they consist of the closely related gamma A-gamma F family and the more distantly related but more conserved gamma S-crystallin. The expression patterns of the family of gamma -crystallins appear to be correlated with the formation of the decreasing refractive index gradient from the center to the cortex of the adult lens (4, 10). The propensity of certain gamma -crystallins to easily form a concentrated phase (11), such as the high Tc gamma -crystallins that are enriched in the core region of the lens, probably reflects their "attractive" interactions (12). gamma S-crystallin, located in the low refractive index outer regions of the lens, is characterized by more repulsive intermolecular interactions (13). The molecular basis for the stability of these long-lived structural proteins, along with their solution intermolecular interactions that govern solubility and phase separation behavior, are areas of cataract research.

Several x-ray structures of gamma A-F crystallins are now known, and they all show very similar two-domain pairing about a hydrophobic interface that contributes toward stability (14-17). gamma S-crystallin is a major structural protein in the human eye lens (18). Human and bovine gamma S-crystallins and their isolated domains are very stable and show two-state unfolding, allowing detailed quantitative thermodynamic properties of the proteins to be evaluated (19). Computer simulations of heat-induced unfolding of bovine gamma B-crystallin also indicate high stability and furthermore suggest that the first stage of unfolding involves the dissociation of the paired domains (20). Conformational changes to aging crystallins can derive from a variety of covalent changes. Oxidation of cysteine and methionine residues have been detected in human crystallins (21). Deamidation of human gamma -crystallins is correlated with aging (22, 23) and with increased insolubilization of crystallins, particularly gamma S (21). Deamidation alters the charge balance, adding a negative charge to a previously neutral area, but it is also thought to mark the nonenzymic formation of isomers such as beta -aspartate that would alter the backbone covalent structure (24).

So far for gamma S-crystallin, only the C-terminal domain of the bovine protein has been solved by x-ray crystallography (25), showing how two domains self-associate to form a dimer in an analogous way to that of the native two-domain gamma -crystallins, although the pairing is less symmetrical. Surprisingly, one of the domains has an altered conformation in its tyrosine corner, a usually highly conserved feature of most beta -sandwich proteins (26). In fact, the tyrosine corner has been proposed as a possible folding nucleus in a prokaryote protein with a related beta gamma -crystallin fold (27), although this has not been universally supported (28). Because it is unclear to what extent the lattice interactions in the crystal structure influenced pairing and conformation, further three-dimensional structures are required. Here we show that the C-terminal domains of human gamma S-crystallin pair about a slightly distorted 2-fold axis to form a dimer with both tyrosine corners in a nonstandard conformation.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Protein Expression-- The human gamma S-crystallin C-terminal domain (HGSC)1 was cloned in the pET3a vector essentially as described for the C-terminal domain of calf gamma S-crystallin (25). The novel initiation codon was introduced in the human gamma S sequence (19) at a position that replaced the first glycine in the linker sequence by PCR-mediated mutagenesis using the following primers: GTTCATCTGCCTCATATGGGCCAGTATAAG (forward) and GGATCCATGTCATTACTCCACAATG (reverse).

The HGSC plasmid DNA, coding for residues 91-177 (topologically equivalent to residues 86-172 of gamma B-crystallin) was transformed into Escherichia coli strain BL21(DE3) pLysS competent cells. Colonies were picked to inoculate and grown overnight at 37 °C with shaking in 10 ml of 2YT medium (5 g/liter NaCl, 10 g/liter yeast extract, 16 g/liter peptone 140) with 10 µl of ampicillin (100 mg/ml) and 15 µl of chloramphenicol (34 mg/ml). Large scale growth was performed with an overnight culture of 500 ml of 2YT medium containing 250 µl of ampicillin (50 mg/ml) after inoculation at 100:1 from the 10-ml overnight growths. The flasks were shaken at 37 °C and induced by the addition of 250 µl isopropyl-beta -D-thiogalactopyranoside after the culture was grown to an A550 of 0.4-0.6 (3-4 h). Growth was continued overnight, whereupon cells were harvested by centrifugation at 5000 rpm for 15 min at 4 °C. The pellets were resuspended in 10 ml of 25 mM Tris-HCl, pH8.0, 10 mM EDTA, 50 mM glucose with a protease inhibitor (5 µl of Pefabloc (Merck)) and frozen at -20 °C.

Protein Isolation-- The highly expressed protein was isolated from the soluble fraction. Whole cell lysate was prepared from the thawed pellet by addition of DNase I and MgCl2 to the suspension giving final concentrations of 10 µg/ml and 10 mM, respectively, followed by sonication on ice using 10-s pulses with cooling in between. The pellet was spun down at 20,000 rpm for 30 min at 4 °C before dialyzing the supernatant overnight at 4 °C with stirring against buffer A (25 mM Tris-HCl, pH 8.0, 1 mM EDTA, 1 mM dithiothreitol). The solution was then filtered through a 0.4-µm nitrocellulose filter followed by a 0.2-µm nitrocellulose filter before being loaded onto a Hiload 16/10 Q Sepharose High Performance column (Amersham Biosciences, Inc.). The column was run at 4 ml/min on a Gradifrac with the following program: 1) 20 ml of 100% buffer A; 2) gradient from 0-70% buffer B (buffer B was buffer A with 1 M NaCl) over 160 ml; 3) 60 ml of 100% buffer B; and 4) 100 ml of 100% buffer A. The HGSC peak eluted at about 15% buffer B, in line with the predicted pI of 6.0. The identity of the protein was confirmed by electrospray mass spectrometry with the measured mass of 10,412 being in close agreement with the calculated mass of 10,414 and indicating that the initiating methionine had been cleaved. The HGSC protein fractions were concentrated to ~10 mg/ml and equilibrated against 25 mM Bis-Tris-propane HCl, pH 7.5, using an Amicon (Millipore, Watford, Hertfordshire, UK) cell equipped with a YM3 membrane. The concentrated protein was stored at -20 °C.

The size of the protein was estimated using chromatography on a Superose 12HR 10/30, using 25 mM Bis-Tris-propane HCl, 0.2 M NaCl, pH 6.5 or 8.0, as running buffer. The HGSC eluted at 15.3 ml, over a wide range of protein concentration application (0.2-6.5 mg/ml) at both pH 6.5 and 8.0. For comparison, full-length bovine gamma S-crystallin at pH 8.0 elutes at 14.4 ml, in agreement with the monomeric nature of the C-terminal domain of human gamma S in solution, as determined using ultracentrifugation (19).

Crystallization-- The crystals were grown using the hanging drop vapor diffusion method with conditions for crystal growth optimized from Hampton (Laguna Niguel, CA) Crystal Screen II condition 13, with polyethylene glycol monomethylether 2000 as precipitant. 1 µl of protein at ~10 mg/ml 25 mM Bis-Tris-propane HCl, pH 7.5, was added to 1 µl of well solution containing 0.2 M ammonium sulfate, 0.1 M sodium acetate, pH 5.0, and 20-28% polyethylene glycol monomethylether 2000. The optimum crystals, formed at 24% polyethylene glycol monomethylether 2000 after 4 days growth at room temperature, were hexagonal bipyramidal with dimensions of ~0.3 × 0.1 × 0.1 mm3.

Data Collection and Processing-- Intensity data to 2.4 Å were collected from a cryo-cooled (100 K) crystal using the Daresbury SRS source at Station 9.6 using an ADSC imaging plate. No cryoprotectant was added. The data were processed using the program MOSFLM (29). Scaling was carried out with the program SCALA (30), and the data were truncated with TRUNCATE (31). The crystals were either space group P6122 or P6522 with two molecules in the asymmetric unit assuming a solvent content of 61% (Vm = 3.15 Å3/dalton). The crystal data and statistics from data processing are listed in Table I.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Crystallographic data

Structure Determination-- Molecular replacement was undertaken with the program AMoRe (32) with the B chain coordinates from the bovine gamma S-C domain (25) as a search model. Data from 15-2.4 Å were used in both the rotation and translation function searches with a Patterson cut-off radius of 15 Å and a radius of integration of 0.75% (the maximal distance from the center of mass being 21.5 Å). A successful solution was found indicating two molecules in the asymmetric unit, using the P6522 space group, with a correlation coefficient of 63.7 and an R factor of 42.3%.

Structure Refinement-- Refinement of the structure was undertaken using CNSsolve version 0.9 (33). The reflections were divided, at random, into working and test (7.5% of the data) sets, to allow both the crystallographic and free R factors to be followed. The test set of reflections was excluded from the map calculations. Early in refinement, the noncrystallographic symmetry at the dimer interface was maintained by use of restraints (initial noncrystallographic symmetry restraints were 20 kcal/mol). Both simulated annealing and minimization methods were tried for refinement, with a maximum likelihood target using amplitudes. The refinement method giving the best reduction in the R factors for a cycle was chosen, and individual isotropic B-factor refinement was then undertaken. In each cycle, both 2Fo - Fc and Fo - Fc electron density maps were calculated, and manual rebuilding was undertaken using the program O (34). Water molecules were added using the CCP4 (35) programs PEAKMAX and WATPEAK to select potential sites. Some later rounds of refinement were undertaken using the CCP4 programs REFMAC (36) and ARP_WARP (37) interspersed with CNSsolve refinement. Noncrystallographic symmetry restraints were lowered to 5 kcal/mol and finally removed. The final values for a crystallographic R factor of 21.6% and for a free R factor of 26.4% were obtained after 35 cycles of refinement.

The final solution contains two molecules of human gamma S-crystallin C-domain (A and B) in the asymmetric unit, together with 90 water molecules. The statistics after refinement are given in Table II. Electron density for all the residues is visible, with just some side chain density remaining unclear. The Ramachandran plot from PROCHECK (38) shows 86.2% of the residues in the most favored regions and 13.8% in the additional allowed regions. The coordinates have been deposited in the RCSB protein data bank, under code number 1ha4.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Refinement statistics

Solvent Accessibility-- The program NACCESS (39) was used to calculate solvent accessible surface areas using the default probe radius of 1.4Å.

Figures-- The figures were produced using the programs MOLMOL (40) and POVRAY version 3.1.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Human gamma S-crystallin C-terminal Domain Forms a "Dimer" in the Crystal Lattice-- The refined electron density shows that the two molecules of the HGSC in the asymmetric unit have a very similar structure (backbone root mean square deviation of 0.29 Å), and they are very similar to bovine gamma B-crystallin C-terminal domain (BGBC) (backbone root mean square deviation of 0.8 Å). The two HGSC domains form a dimer with a rotation of 176.5° between the two chains (red in Fig. 1A). This 2-fold pairing of two C-terminal domains is similar to the N- and C-terminal domain pairing in other polypeptides of the beta gamma -crystallin family and is considered to reflect the origin of the family from an ancestral homodimer of single domains (41). Further evidence for the ancestral homodimer model is provided by the crystal structure of the C-terminal domain of bovine gamma B-crystallin in which the C-terminal tyrosine was deleted. The two domains paired about a slightly distorted noncrystallographic 2-fold axis (BGBC, blue in Fig. 1A) and are readily superposed on the native 2-domain gamma B-crystallin (42). However, when the C-terminal domain of bovine gamma S-crystallin was solved, the two molecules in the asymmetric unit were found to pair in a broadly similar way (BGSC, green in Fig. 1A), but the 2-fold is distorted by around 20 °C (25).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 1.   Dimer of human gamma S-crystallin C-terminal domains. A, a superposition of the HGSC dimer, the BGSC dimer, and the BGBC (42) dimer. The backbone is colored according to the protein. The black arrows point to the tyrosine corners where the proteins show the largest differences, whereas the gray arrows point to residues 99-103, which are involved in dimer-dimer interactions. B, sequence alignment of the C-terminal domains of human (HGSC) and bovine gamma S (BGSC) with bovine gamma B-crystallin (BGBC). The residues mentioned in the text as being involved in interactions between domains are highlighted. The tyrosine corner sequence is underlined.

The residues in the interface between the two domains in HGSC are shown in Fig. 2. It should be noted that the residue numbers used here are based on the alignment of the domain to gamma B-crystallin not from the gamma S-crystallin sequence (Fig. 1B). In common with other beta gamma -crystallin paired domain interfaces, there is a central hydrophobic patch (shown in green) surrounded by polar residues that make specific interactions. For example, in the HGSC dimer, there are two ion pairs between Asp147 and Arg168 on each side of the noncrystallographic axis, whereas in the BGSC distorted dimer, only one ion pair can form (see Fig. 4 in Ref. 25). A cluster of interactions is close to the 2-fold axis: each Gln143 and Glu172 side chain interacts with backbone polar atoms of its symmetrically related partner, and each Arg142 interacts with its symmetrically related partner side chain. The only sequence difference between the two species at the interface is Val130 in human that replaces alanine in the bovine and is likely to contribute to the differing symmetries.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 2.   gamma S C-domain dimer interface. The backbone of chain A (black) and chain B (gray) are shown with interface residues colored such that the acidic residues (Asp147 and Glu172) are in red, the basic residues (Arg142 and Arg168) are in blue, the hydrophobic residues (Val130, Leu145, and Ile170) are in green, and the polar residue (Gln143) is in purple.

Tyrosine Corner Structure-- It is apparent from a superposition of three kinds of gamma -crystallin C-terminal domain dimers that there are two regions, calculated using difference distance plots (43), where the domain conformation differs: the tyrosine corners and a dimer-dimer interface region (Fig. 1A). When tyrosine corners from four C-terminal domains of members of the beta gamma -crystallin superfamily (HGSC, BGSC, BGBC, and the C-terminal domain of bovine beta B2-crystallin) are compared, HGSC has a backbone conformation that follows that of the BGSC A chain rather than the more common conformation seen in BGBC and the C-terminal domain of bovine beta B2-crystallin. Fig. 3A shows a comparison of the HGSC tyrosine corner with that from BGBC. The unusual conformation is centered near residue 148 where gamma B has proline and gamma S has lysine. In the "standard" conformation, the tyrosine (151) hydroxyl oxygen hydrogen bonds with the main chain N-H of Asp147 (bond length, 2.4 Å). In HGSC, the tyrosine hydrogen bonds with the main chain N-H of Lys148 (bond length, 1.96 Å). The new corner conformation results in different positions for the exposed positive charges of lysines 148 and 149 (Fig. 3A).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 3.   The tyrosine corner in human gamma S-crystallin. A, the two chains of the human gamma S C-terminal domains and the two chains of bovine gamma B C-terminal domains have been superposed to show the different hydrogen bonding patterns in the two types of tyrosine corner. The yellow hydrogen bond occurs in the standard conformation from BGBC (in red), where the side chain oxygen of Tyr151 hydrogen bonds to the main chain N-H of Arg147, this conformation being the same as that found in the B chain of BGSC. The turquoise hydrogen bonds occur in the unusual conformation from HGSC (in blue), where Tyr151 hydrogen bonds to Lys148 main chain nitrogen. This conformation is the same as that found in the A chain of BGSC. B, an alignment of some human beta gamma -crystallin C-terminal domain tyrosine corner sequences shows the conservation of at least one of Pro148 or Gly149 (shown in red) in all sequences except for gamma S.

Dimer-Dimer Interactions in Human gamma S-C-- There are three different interdimer interfaces present in the crystal lattice (Fig. 4). The solvent accessible surface areas have been calculated for the single HGSC chains, for the AB dimer on its own (Chains A and B together), and for the AB dimer with its symmetrically related partners. These data are shown in Table III. When the amounts of buried surface area in the three lattice interfaces are compared with the area buried within the dimer, it can be seen that the interface between the chains in the dimer buries 10.9% of the monomer surface, whereas lattice interfaces 1, 2, and 3 bury 9.3, 6.6, and 2.8%, respectively. Interface 1 is thus nearly as extensive as the dimer interface and is similar to one of the four lattice interfaces found in the bovine lattice (data not shown). His117, a residue in the long loop region between strands c and d of the first Greek key motif, participates to some extent in all three interfaces (Fig. 4).


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 4.   Residues that dominate lattice interactions. The dimer in the asymmetric unit makes three lattice interactions. The green residue His117(122) is involved in all three, with involvement of the purple residues Gln115(120) in interface 1 (A) and Gln101(106) in both interfaces 2 (B) and 3 (C). These residues are likely to contribute toward the short range interactions in the normal human lens.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Solvent-accessible surface areas

It is residues in the smaller HGSC interface 3 that show the major conformational differences when compared with other gamma -crystallin C-terminal domains (Fig. 4C). Only one of the residues that differs between the human and the bovine sequences is involved in lattice interactions for the human form. This is tyrosine 103 that interacts with conserved glutamine 101 in interface 3, whereas this residue is a histidine in the bovine protein.

The Cysteine and Amide Sites-- The solvent accessibilities of Cys109 (Cys114 in gamma S numbering) 3.7 Å2 and Cys124 (Cys129 in gamma S numbering) 0.0 Å2 are low because they are buried in the domain core with their SG atoms 13 Å apart. There is no indication of oxidation. The exposure of the amide containing amino acids, calculated for the A chain from an AB dimer, are ranked in order of accessibility: Gln87(92) 130.0 Å2; Gln115(120), 105.1 Å2; Gln101(106), 100.1 Å2; Asn138(143), 97.2 Å2; Gln165(170), 50.9 Å2; Gln91(96), 30.6 Å2; and Gln143(148), 18.4 Å2 (Fig. 5). The least accessible, Gln143(148), is buried in the dimer interface and would likely be packed against the N-terminal domain in the intact two-domain gamma S molecule. The side chain of Asn138(143), a residue shown to be deamidated in human cataract (44), is not involved in hydrogen bonding to either backbone or side chain atoms of neighboring residues; therefore deamidation will not destabilize the molecule by disruption of hydrogen bonds. At neutral pH, the C-terminal domain of gamma S-crystallin has a charge of -1, and the addition of another negative charge by deamidation of Asn138(143) may contribute to a decrease in stability. Charged residues within 10 Å (chosen as a value for the limit of electrostatic effects), which may be perturbed by the addition of a negative charge are: Glu114(119), Glu135(140), Arg140(145), and Arg168(173). The most important of these interactions is likely to be that of Asn138(143) with Glu114(119) because the closest atoms of these two residues are the termini of the side chains (7.2 Å apart).


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 5.   Location of the amide residues. The side chains of asparagine (green) and glutamine (red) residues appended to a backbone trace of HGSC show their even distribution over the domain surface. Gln101(106) and Gln115(120), the amides involved in lattice interactions, have similar surface accessibilities as Asn138(143), which is known to be deamidated in cataract. Gln101(106) and Asn138(143) are situated on each of the highly ordered beta -hairpin loops.

The two-domain human gamma S-crystallin was modeled using the complete bovine gamma B-crystallin as a template, with the C-terminal domain replaced by the human gamma S coordinates and the residues in the N-domain mutated to match the human gamma S sequence. In this model, the only residue on the N-terminal domain that is within 10 Å of Asn138(143) is Met69(73), with the main chain carbonyl of Asn138(143) being 8.8 Å from the side chain of Met69(73). This interaction with methionine is also seen in the x-ray structures of bovine gamma D-, gamma E-, and gamma F-crystallins, but at a distance of 6.3-6.5 Å, and it is the only residue from the N-terminal domain within 10 Å of Asn138(143). Deamidation of Asn138(143) is thus unlikely to perturb electrostatic interactions in the N-terminal domain.

Two other amide containing residues are involved in lattice contacts: Gln115(120) and Gln101(106). Gln115(120) hydrogen bonds to Thr105(110) and Thr106(111) and is close to Glu107(112) in interface 1 (Fig. 4A). This residue is also involved in a similar interaction in the lattice of the bovine gamma S-crystallin C-terminal domain dimer. In HGSC interface 2, Gln101(106) from chain A interacts with the main chain of two residues from chain B: Arg119(124) and Glu120(125) (Fig. 4B) and in interface 3 (Fig. 4C), it interacts with its symmetrically related partner as well as with Met102(107) and Tyr103(108).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The human gamma S-crystallin C-terminal domain forms dimers in the crystal lattice (although not in solution) using a similar interface to those observed between N- and C-terminal domains in other beta gamma -crystallins and is likely to form a similar intramolecular interface with its own N-terminal domain. The dyad is more exact than in the corresponding bovine gamma S construct. The recreation of these 2-fold interactions between single domains underscores the idea that domain pairing is an ancestral dimer trait. However, without the covalent linker, the local concentration of a single domain is insufficient to form a dimer in solution (19). The weakness of the interface interaction renders it susceptible to deformation, and it is the first likely hydrophobic surface to become water exposed during denaturation, in line with computer simulated unfolding studies of gamma B-crystallin (20).

The tyrosine corner is an extremely conserved structural feature of the beta gamma -crystallin fold. In common with other beta -sandwich domains, it occurs only once in the domain, even though the beta gamma -crystallin domain is made from two similar Greek key motifs (Fig. 1B). Here it is shown that in the human gamma S-crystallin C-terminal domain, the tyrosine corner conformation in both partners of the dimer is nonstandard. In the corresponding bovine gamma S-crystallin structure, where the two domains in the asymmetric unit (chains A and B) pair about a distorted 2-fold axis, the major conformational difference between the chains is in the tyrosine corner, with chain A having an unusual conformation. However, it was not possible to ascertain whether this was due to the distorted 2-fold pairing and/or was a consequence of crystal lattice interactions (25). We hypothesize that the tyrosine corner structure seen in both chains of the human gamma S-crystallin C-terminal domain, as well as the A chain of the bovine gamma S-crystallin C-terminal domain, is the favored conformation for gamma S-crystallins. The consensus sequence for the tyrosine corner is LXPGXY, whereas in gamma S-crystallin C-terminal domain it is LDKKEY with the lysine pair that replaces proline-glycine increasing the energy of the standard tyrosine corner polyproline II conformation. The more usual gamma -crystallin conformation found in the crystal form of the B chain of the C-terminal domain from bovine gamma S-crystallin is probably being stabilized by the side chain of Lys148(153). This forms a salt bridge with the C-terminal carboxylate of chain A, giving a compensation for the higher energy conformation of the backbone. Now that the new conformation has been seen in a gamma S-crystallin in a different lattice, it is likely to be independent of a secondary lattice effect. It will be interesting to ascertain whether this new conformation contributes to the lower stability of gamma S-crystallin toward denaturants compared with gamma B-crystallin (19) and/or affects the folding.

The human gamma S C-terminal domain sequence is very similar to the bovine (93% identical). Although the two species of crystals are grown under very similar conditions, they have different space groups (human, P6522; bovine, P6122) and form two kinds of dimer, one almost perfect and one distorted. Only one of the residues that differs between the human and the bovine sequences is involved in lattice interactions, this being Tyr103(108) in the human form. This bulky residue occupies a position at an extremity of the molecule, a position that is involved in lattice interactions in other gamma -crystallins (14). It is likely to be responsible for the differing space groups and hence different lattice contacts in gamma S-crystallin and may play a role in the short range interactions in the eye lens.

Because deamidation is a commonly observed post-translational modification in the long-lived crystallins, it is possible that the addition of a negative charge could disturb the short range repulsive interactions of human gamma S-crystallin (13). Two highly exposed glutamines (at positions 101(106) and 115(120)) are involved in lattice interactions, the latter in both human and bovine crystal structures. Deamidation of these glutamines may thus have implications for the interactions of gamma S-crystallins in the lens.

Human gamma S-crystallin has to last a lifetime and thus requires both thermodynamic and kinetic stabilization. A recently described mouse gamma S-crystallin gene that carries a point mutation provides a model for how a properly folded but destabilized protein can cause cataracts (45). Mechanisms for loss of stability leading to aggregation and light scattering in human senile cataracts have invoked post-translational modifications involving cysteine oxidation and deamidation. The two cysteines, Cys109(114) and Cys124(129), that are buried in the C-terminal domain of human gamma S-crystallin remain reduced during crystal growth without the addition of reducing agents in keeping with the stability of the native domain fold. An interesting question is whether deamidation contributes to domain destabilization and hence increases the chances of the buried cysteines becoming exposed and available for cross-linking.

It has been shown that the tryptic peptide containing Asp138(143) is deamidated when isolated from human cataractous lens proteins (44), whereas when the corresponding peptide is isolated from the fetal-embryonic region of aged transparent human lenses, it is not deamidated (46). Asp138(143) is in the region of the domain dimer interface but has a moderate solvent exposure (Fig. 5). The addition of a negative charge in place of the neutral asparagine is likely to perturb Glu114(119), but weakly because it is some distance away. Recently, more than 40% of residue Asn138(143) in human cataractous lenses has been identified as being in the beta -aspartate form (47). Identification of this modification, along with the occurrence of racemization at this site, further substantiates the hypothesis that deamidation can occur via a preferred succinimidyl intermediate (48). Deamidation is thus a useful marker of a more radical structural change to the protein that involves addition of extra carbons to the polypeptide backbone and tends to be correlated with flexibility of the protein backbone chain (24). It is significant that Asn138(143) is in the highly ordered folded beta -hairpin structure that is involved in maintaining the tertiary beta gamma -crystallin fold (4). If deamidation were to occur to the native protein at this site leading to an altered covalent backbone structure, it would likely destabilize the gamma S-crystallin domain. Because this residue is resistant to deamidation in the normal aged human gamma S-crystallin (46), it is unknown whether the molecule has first to be unfolded prior to deamidation or whether other cataractogenic factors are involved that favor deamidation, which then leads to unfolding.

    ACKNOWLEDGEMENTS

We acknowledge Dr. Claire Naylor for help with data collection, processing, and refinement, Dr. Ajit Basak for help with crystallization and data collection, and the staff at station 9.6 at the Daresbury laboratory.

    FOOTNOTES

* This work was supported by BioMed Program of the European Community Grant BMH4-CT98-3895 and by the Medical Research Council and the Biotechnology and Biological Sciences Research Council London Structural Biology Center.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The atomic coordinates and structure factors (code 1ha4) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

§ Supported by a BBSRC studentship. To whom correspondence should be addressed. Tel.: 44-20-7631-6869; Fax: 44-20-7631-6803; E-mail: a.purkiss@mail.cryst.bbk.ac.uk.

Published, JBC Papers in Press, November 8, 2001, DOI 10.1074/jbc.M110083200

    ABBREVIATIONS

The abbreviations used are: HGSC, human gamma S-crystallin C-terminal domain; BGBC, bovine gamma B-crystallin C-terminal domain; BGSC, bovine gamma S-crystallin C-domain.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Derham, B. K., and Harding, J. J. (1999) Prog. Retinal Eye Res. 18, 463-509[CrossRef][Medline] [Order article via Infotrieve]
2. Horwitz, J. (2000) Semin. Cell Dev. Biol. 11, 53-60[CrossRef][Medline] [Order article via Infotrieve]
3. Das, K. P., Choo-Smith, L. P., Petrash, J. M., and Surewicz, W. K. (1999) J. Biol. Chem. 274, 33209-33212[Abstract/Free Full Text]
4. Slingsby, C., Norledge, B., Simpson, A., Bateman, O. A., Wright, G., Driessen, H. P. C., Lindley, P. F., Moss, D. S, and Bax, B. (1997) Prog. Ret. Eye Res. 16, 3-29
5. Mayr, E.-M., Jaenicke, R., and Glockshuber, R. (1997) J. Mol. Biol. 269, 260-269[CrossRef][Medline] [Order article via Infotrieve]
6. Palme, S., Slingsby, C., and Jaenicke, R. (1997) Protein Sci. 6, 1529-1536[Abstract]
7. Trinkl, S., Glockshuber, R., and Jaenicke, R. (1994) Protein Sci. 3, 1392-1400[Abstract]
8. Bax, B., Lapatto, R., Nalini, V., Driessen, H., Lindley, P. F., Mahadevan, D., Blundell, T. L., and Slingsby, C. (1990) Nature 347, 776-780[CrossRef][Medline] [Order article via Infotrieve]
9. Lubsen, N. H., Aarts, H. J. M., and Schoenmakers, J. G. G. (1988) Prog. Biophys. Mol. Biol. 51, 47-76[CrossRef][Medline] [Order article via Infotrieve]
10. de Jong, W. W., Lubsen, N. H., and Kraft, H. J. (1994) Prog. Retinal Eye Res. 13, 391-442[CrossRef]
11. Broide, M. L., Berland, C. R., Pande, J., Ogun, O. O., and Benedek, G. B. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 5660-5664[Abstract/Free Full Text]
12. Tardieu, A., Vérétout, F., Krop, B., and Slingsby, C. (1992) Eur. Biophys. J. 21, 1-12[Medline] [Order article via Infotrieve]
13. Skouri-Panet, F., Bonneté, F., Prat, K., Bateman, O. A., Lubsen, N. H., and Tardieu, A. (2001) Biophys. Chem. 89, 65-76[CrossRef][Medline] [Order article via Infotrieve]
14. Chirgadze, Y. N., Driessen, H. P. C., Wright, G., Slingsby, C., Hay, R. E., and Lindley, P. F. (1996) Acta Crystallogr. Sect. D Biol. Crystallogr. 52, 712-721[CrossRef]
15. Norledge, B. V., Hay, R. E., Bateman, O. A., Slingsby, C., and Driessen, H. P. C. (1997) Exp. Eye Res. 65, 609-630[CrossRef][Medline] [Order article via Infotrieve]
16. Palme, S., Jaenicke, R., and Slingsby, C. (1998) Protein Sci. 7, 611-618[Abstract]
17. Palme, S., Jaenicke, R., and Slingsby, C. (1998) J. Mol. Biol. 279, 1053-1059[CrossRef][Medline] [Order article via Infotrieve]
18. Lampi, K. J., Ma, Z., Shih, M., Shearer, T. R., Smith, J. B., Smith, D. L., and David, L. L. (1997) J. Biol. Chem. 272, 2268-2275[Abstract/Free Full Text]
19. Wenk, M., Herbst, R., Hoeger, D., Kretschmar, M., Lubsen, N. H., and Jaenicke, R. (2000) Biophys. Chem. 86, 95-108[CrossRef][Medline] [Order article via Infotrieve]
20. Purkiss, A. G., Slingsby, C., and Goodfellow, J. M. (2000) Protein Peptide Lett 7, 211-217
21. Hanson, S. R. A., Hasan, A., Smith, D. L., and Smith, J. B. (2000) Exp. Eye Res. 71, 195-207[CrossRef][Medline] [Order article via Infotrieve]
22. Hanson, S. R. A., Smith, D. L., and Smith, J. B. (1998) Exp. Eye Res. 67, 301-312[CrossRef][Medline] [Order article via Infotrieve]
23. Ma, Z., Hanson, S. R. A., Lampi, K. J., David, L. L., Smith, D. L., and Smith, J. B. (1998) Exp. Eye Res. 67, 21-30[CrossRef][Medline] [Order article via Infotrieve]
24. Aswad, D. W., Paranandi, M. V., and Schurter, B. T. (2000) J. Pharmacol. Biomed. Anal 21, 1129-1136
25. Basak, A. K., Kroone, R. C., Lubsen, N. H., Naylor, C. E., Jaenicke, R., and Slingsby, C. (1998) Protein Eng. 11, 337-344[Abstract/Free Full Text]
26. Hemmingsen, J. M., Gernert, K. M., Richardson, J. S., and Richardson, D. C. (1994) Protein Sci. 3, 1927-1937[Abstract]
27. Bagby, S., Go, S., Inouye, S., Ikura, M., and Chakrabartty, A. (1998) J. Mol. Biol. 276, 669-681[CrossRef][Medline] [Order article via Infotrieve]
28. Hamill, S. J., Cota, E., Chothia, C., and Clarke, J. (2000) J. Mol. Biol. 295, 641-649[CrossRef][Medline] [Order article via Infotrieve]
29. Powell, H. R. (1999) Acta Cryst. D55, 1690-1695
30. Evans, P. R. (1997) in Proceedings of CCP4 Study Weekend on Recent Advances in Phasing, August 1997 (Wilson, K. S. , Davies, G. , Ashkon, A. W. , and Bailey, S., eds) , pp. 97-102, CCLRC, Daresbury Laboratory, Warrington, UK
31. French, G. S., and Wilson, K. S. (1978) Acta Crystallogr. Sect. A 34, 517-525[CrossRef]
32. Navaza, J. (1994) Acta Crystallogr. Sect. A 50, 157-163[CrossRef]
33. Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J.-S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Acta Crystallogr. Sect. D Biol. Crystallogr. 54, 905-921[CrossRef][Medline] [Order article via Infotrieve]
34. Jones, T. A., Zou, J.-Y., Cowan, S. W., and Kjeldgaard, M. (1994) Acta Crystallogr. Sect. A 47, 110-119[CrossRef]
35. Collaborative Computational Project, Number 4. (1994) Acta Crystallogr. Sect. D Biol. Crystallogr. 50, 760-763[CrossRef][Medline] [Order article via Infotrieve]
36. Murshudov, G. N., Vagin, A. A., and Dodson, E. J. (1997) Acta Crystallogr. Sect. D Biol. Crystallogr. 53, 240-255[CrossRef][Medline] [Order article via Infotrieve]
37. Lamzin, V. S., and Wilson, K. S. (1997) Methods Enzymol. 277, 269-305[Medline] [Order article via Infotrieve]
38. Laskowski, R. A., MacArthur, M. W., Moss, D. S., and Thornton, J. M. (1993) J. Appl. Crystallogr. 26, 283-291[CrossRef]
39. Hubbard, S. J., and Thornton, J. M. (1993) NACCESS , Computer Program, Department of Biochemistry and Molecular Biology, University College, London, UK
40. Koradi, R., Billeter, M., and Wüthrich, K. (1996) J. Mol. Graphics 14, 51-55[CrossRef][Medline] [Order article via Infotrieve]
41. Blundell, T., Lindley, P., Miller, L., Moss, D., Slingsby, C., Tickle, I., Turnell, B., and Wistow, G. (1981) Nature 289, 771-777[CrossRef][Medline] [Order article via Infotrieve]
42. Norledge, B. V., Mayr, E.-M., Glockshuber, R., Bateman, O. A., Slingsby, C., Jaenicke, R., and Driessen, H. P. C. (1996) Nat. Struct. Biol. 3, 267-274[CrossRef][Medline] [Order article via Infotrieve]
43. Purkiss, A. G. (1999) Contax: Protein Distance Difference Plots (luing.cryst.bbk.ac.uk/bpurk01/work/contax 2.html)
44. Takemoto, L., and Boyle, D. (2000) Mol. Vision 6, 164-168[Medline] [Order article via Infotrieve]
45. Sinha, D., Wyatt, M. K., Sarra, R., Jaworski, C., Slingsby, C., Thaung, C., Pannell, L., Robison, W. G., Favor, J., Lyon, M., and Wistow, G. (2001) J. Biol. Chem. 276, 9308-9315[Abstract/Free Full Text]
46. Takemoto, L, and Boyle, D. (2000) J. Biol. Chem. 275, 26109-26112[Abstract/Free Full Text]
47. Takemoto, L., Fujii, N., and Boyle, D. (2001) Exp. Eye Res 72, 559-563[CrossRef][Medline] [Order article via Infotrieve]
48. Geiger, T., and Clarke, S. (1987) J. Biol. Chem. 262, 785-794[Abstract/Free Full Text]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Protein Sci.Home page
I. A. Mills, S. L. Flaugh, M. S. Kosinski-Collins, and J. A. King
Folding and stability of the isolated Greek key domains of the long-lived human lens proteins {gamma}D-crystallin and {gamma}S-crystallin
Protein Sci., November 1, 2007; 16(11): 2427 - 2444.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
Z. Wu, F. Delaglio, K. Wyatt, G. Wistow, and A. Bax
Solution structure of {gamma}S-crystallin by molecular fragment replacement NMR
Protein Sci., December 1, 2005; 14(12): 3101 - 3114.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/6/4199    most recent
M110083200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Purkiss, A. G.
Right arrow Articles by Slingsby, C.